Sclerostin small molecule inhibitors promote osteogenesis by activating canonical Wnt and BMP pathways

  1. Sreedhara Sangadala
  2. Chi Heon Kim
  3. Lorenzo M Fernandes
  4. Pooja Makkara
  5. George R Beck
  6. Scott D Boden
  7. Hicham Drissi  Is a corresponding author
  8. Steven M Presciutti  Is a corresponding author
  1. Emory University, United States
  2. Panjab University, India
  3. Atlanta VA Medical Center, United States

Abstract

Background: The clinical healing environment after a posterior spinal arthrodesis surgery is one of the most clinically challenging bone healing environments across all orthopaedic interventions due to the absence of a contained space and the need to form de novo bone. Our group has previously reported that sclerostin in expressed locally at high levels throughout a developing spinal fusion. However, the role of sclerostin in controlling bone fusion remains to be established.

Methods: We computationally identified two FDA-approved drugs, as well as a single novel small molecule drug, for their ability to disrupt the interaction between sclerostin and its receptor, LRP5/6. The drugs were tested in several in vitro biochemical assays using murine MC3T3 and MSCs, assessing their ability to: (1) enhance canonical Wnt signaling, (2) promote the accumulation of the active (non-phosphorylated) form of b-catenin, and (3) enhance the intensity and signaling duration of BMP signaling. These drugs were then tested subcutaneously in rats as standalone osteoinductive agents on plain collagen sponges. Finally, the top drug candidates (called VA1 and C07) were tested in a rabbit posterolateral spine fusion model for their ability to achieve a successful fusion at 6 weeks.

Results: We show that by controlling GSK3b phosphorylation, our three SMIs simultaneously enhance canonical Wnt signaling and potentiate canonical BMP signaling intensity and duration. We also demonstrate that the SMIs produce dose-dependent ectopic mineralization in vivo in rats as well as significantly increase posterolateral spine fusion rates in rabbits in vivo, both as standalone osteogenic drugs and in combination with autologous iliac crest bone graft.

Conclusions: Few if any osteogenic small molecules possess the osteoinductive potency of BMP itself – that is, the ability to form de novo ectopic bone as a standalone agent. Herein, we describe two such SMIs that have this unique ability and were shown to induce de novo bone in a stringent in vivo environment. These SMIs may have the potential to be used in novel, cost-effective bone graft substitutes for either achieving spinal fusion or in the healing of critical-sized fracture defects.

Funding: This work was supported by a Veteran Affairs Career Development Award (IK2-BX003845).

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file.

Article and author information

Author details

  1. Sreedhara Sangadala

    Department of Orthopaedics, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Chi Heon Kim

    Department of Orthopaedics, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Lorenzo M Fernandes

    Department of Orthopaedics, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Pooja Makkara

    Department of Biotechnology, Panjab University, Chandigarh, India
    Competing interests
    The authors declare that no competing interests exist.
  5. George R Beck

    Department of Medicine, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Scott D Boden

    Department of Medicine, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Hicham Drissi

    Department of Medicine, Emory University, Atlanta, United States
    For correspondence
    hicham.drissi@emory.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3322-281X
  8. Steven M Presciutti

    Atlanta VA Medical Center, Decatur, United States
    For correspondence
    prescius33@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6547-9495

Funding

U.S. Department of Veterans Affairs (IK2-BX003845)

  • Lorenzo M Fernandes

U.S. Department of Veterans Affairs (I01BX001516)

  • George R Beck

U.S. Department of Veterans Affairs (I01 BX004708)

  • Hicham Drissi

U.S. Department of Veterans Affairs (I01 BX004878)

  • Hicham Drissi

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All rat and rabbit surgeries and procedures were first approved (#VOOS-14 - 2016-020211) by the Atlanta VA Medical Center Institutional Animal Care and Use Committee (IACUC).

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 681
    views
  • 117
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Sreedhara Sangadala
  2. Chi Heon Kim
  3. Lorenzo M Fernandes
  4. Pooja Makkara
  5. George R Beck
  6. Scott D Boden
  7. Hicham Drissi
  8. Steven M Presciutti
(2023)
Sclerostin small molecule inhibitors promote osteogenesis by activating canonical Wnt and BMP pathways
eLife 12:e63402.
https://doi.org/10.7554/eLife.63402

Share this article

https://doi.org/10.7554/eLife.63402

Further reading

    1. Cell Biology
    Fatima Tleiss, Martina Montanari ... C Leopold Kurz
    Research Article

    Multiple gut antimicrobial mechanisms are coordinated in space and time to efficiently fight foodborne pathogens. In Drosophila melanogaster, production of reactive oxygen species (ROS) and antimicrobial peptides (AMPs) together with intestinal cell renewal play a key role in eliminating gut microbes. A complementary mechanism would be to isolate and treat pathogenic bacteria while allowing colonization by commensals. Using real-time imaging to follow the fate of ingested bacteria, we demonstrate that while commensal Lactiplantibacillus plantarum freely circulate within the intestinal lumen, pathogenic strains such as Erwinia carotovora or Bacillus thuringiensis, are blocked in the anterior midgut where they are rapidly eliminated by antimicrobial peptides. This sequestration of pathogenic bacteria in the anterior midgut requires the Duox enzyme in enterocytes, and both TrpA1 and Dh31 in enteroendocrine cells. Supplementing larval food with hCGRP, the human homolog of Dh31, is sufficient to block the bacteria, suggesting the existence of a conserved mechanism. While the immune deficiency (IMD) pathway is essential for eliminating the trapped bacteria, it is dispensable for the blockage. Genetic manipulations impairing bacterial compartmentalization result in abnormal colonization of posterior midgut regions by pathogenic bacteria. Despite a functional IMD pathway, this ectopic colonization leads to bacterial proliferation and larval death, demonstrating the critical role of bacteria anterior sequestration in larval defense. Our study reveals a temporal orchestration during which pathogenic bacteria, but not innocuous, are confined in the anterior part of the midgut in which they are eliminated in an IMD-pathway-dependent manner.

    1. Cancer Biology
    2. Cell Biology
    Kourosh Hayatigolkhatmi, Chiara Soriani ... Simona Rodighiero
    Tools and Resources

    Understanding the cell cycle at the single-cell level is crucial for cellular biology and cancer research. While current methods using fluorescent markers have improved the study of adherent cells, non-adherent cells remain challenging. In this study, we addressed this gap by combining a specialized surface to enhance cell attachment, the FUCCI(CA)2 sensor, an automated image analysis pipeline, and a custom machine learning algorithm. This approach enabled precise measurement of cell cycle phase durations in non-adherent cells. This method was validated in acute myeloid leukemia cell lines NB4 and Kasumi-1, which have unique cell cycle characteristics, and we tested the impact of cell cycle-modulating drugs on NB4 cells. Our cell cycle analysis system, which is also compatible with adherent cells, is fully automated and freely available, providing detailed insights from hundreds of cells under various conditions. This report presents a valuable tool for advancing cancer research and drug development by enabling comprehensive, automated cell cycle analysis in both adherent and non-adherent cells.